Explain this page
Arphra AIPlain-English read on NextCure, Inc.’s valuationNo recent stories.
today
- NXTC Announces Replay Available for Virtual KOL Event Discussing ASCO 2026 Dose Escalation Data from Phase 1 Trial of SIM0505 for Gynecologic Cancers19d
- NXTC Announces Replay Available for Virtual KOL Event Discussing ASCO 2026 Dose Escalation Data from Phase 1 Trial of SIM0505 for Gynecologic Cancers19d
- NextCure Provides Business Update and Reports First Quarter 2026 Financial Results47d
- NextCure and Simcere Zaiming Initiate Dose Optimization for SIM0505 (CDH6 ADC) in Gynecologic Cancers51d
AI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
—
— vs spot
Recommendation
n/a
0 of 0 methods
Method spread
0bull0bear
±5% threshold
Analyst PT consensus: $15.00 (+728.73%)
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +3.43% | -11.71% | -76.88% | -81.79% | -85.85% | -87.24% | -67.62% | -90.27% | -98.16% | -99.24% | -99.24% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Aftermarket
LiveLast trade
$1.81
105 sh
Bid
$1.69
2 sh
Ask
$2.27
5 sh
Spread
$0.580
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Sector & industry today
LiveSectors
- Real Estate+1.01%
- Consumer Cyclical+0.94%
- Energy+0.84%
- Consumer Defensive+0.82%
- Financial Services+0.23%
- Basic Materials-0.11%
- Healthcare-0.18%
- Communication Services-0.18%
- Industrials-0.47%
- Technology-0.85%
- Utilities-1.03%
Top industries (issuer's industry highlighted)
- Biotechnology+3.28%
- Software - Services+9.60%
- Broadcasting+8.34%
- Travel Services+7.87%
- Computer Hardware+4.56%
- Oil & Gas Energy-3.54%
- Electrical Equipment & Parts-3.26%
- Semiconductors-2.12%
- Communication Equipment+2.06%
- REIT - Healthcare Facilities+2.01%
- Drug Manufacturers - Specialty & Generic+1.99%
- Consulting Services-1.97%
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_items- NXTC Announces Replay Available for Virtual KOL Event Discussing ASCO 2026 Dose Escalation Data from Phase 1 Trial of SIM0505 for Gynecologic Cancersglobenewswire.com·Jun 04, 2026
- NXTC Announces Replay Available for Virtual KOL Event Discussing ASCO 2026 Dose Escalation Data from Phase 1 Trial of SIM0505 for Gynecologic Cancersglobenewswire.com·Jun 04, 2026
- NextCure Provides Business Update and Reports First Quarter 2026 Financial Resultsglobenewswire.com·May 07, 2026
- NextCure and Simcere Zaiming Initiate Dose Optimization for SIM0505 (CDH6 ADC) in Gynecologic Cancersglobenewswire.com·May 04, 2026
- NextCure and Simcere Zaiming Initiate Dose Optimization for SIM0505 (CDH6 ADC) in Gynecologic Cancersglobenewswire.com·May 04, 2026
- NextCure and Simcere Zaiming Initiate Dose Optimization for SIM0505 (CDH6 ADC) in Gynecologic Cancersglobenewswire.com·May 04, 2026
Peers
No peer list available for NXTC.
Total assets
—
Total debt
—
Cash & equiv
—
Operating CF
—
Free cash flow
—
Buybacks
—
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|